Search for: "ACTAVIS" Results 261 - 280 of 1,005
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Dec 2017, 2:13 pm
  He took the audience on a rapid and entertaining gallop through the year’s cases, giving personal insights especially on Actavis. [read post]
29 Dec 2017, 1:00 pm
: English translation of Dutch Supreme Court decision in MSD v Teva highlights UK Supreme Court's Actavis decision I Student essays: how to write a good piece? [read post]
28 Dec 2017, 2:44 am by Neil Wilkof
Teva thereby faces the double whammy of not having a proprietary block-buster product to replace COPAXONE plus a declining competitive position in the generic market.Third, the company's declining fortunes in the generic drug area was exacerbated as a result of its acquisition in 2015 of the Actavis generic products division from Allergen. [read post]
25 Dec 2017, 4:06 am
: English translation of Dutch Supreme Court decision in MSD v Teva highlights UK Supreme Court's Actavis decision I Student essays: how to write a good piece? [read post]
21 Dec 2017, 7:09 am
: English translation of Dutch Supreme Court decision in MSD v Teva highlights UK Supreme Court's Actavis decision I Student essays: how to write a good piece? [read post]
12 Dec 2017, 11:02 am
: English translation of Dutch Supreme Court decision in MSD v Teva highlights UK Supreme Court's Actavis decisionWeekly Roundups: Around the IP Blogs! [read post]
7 Dec 2017, 9:34 pm by Patent Docs
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
5 Dec 2017, 12:29 pm by Overhauser Law Offices, LLC
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861, Spreading Implement, (the ‘861 patent), which have been issued by the US Patent Office. [read post]
1 Dec 2017, 6:20 am
The panel discussion was on the doctrine of equivalents following the Actavis v Lilly decision. [read post]
30 Nov 2017, 8:59 pm by Brenda Fulmer
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
24 Nov 2017, 7:07 am by Brian Cordery
Handed down by Henry Carr J on 21 November, Illumina v Premaitha considered aspects of Actavis and much more besides. [read post]
22 Nov 2017, 3:14 am
Guest Kat Eibhlin answers the question by analyzing the recent decision Generics (U.K) v Yeda, a practical application of the Supreme Court’s Actavis v Eli Lilly.Internet and Digital Media Law conference returns to London! [read post]
21 Nov 2017, 1:25 pm by Overhauser Law Offices, LLC
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana, filed suit in the Southern District of Indiana alleging that Defendants, Actavis LLC of Parsippany, New Jersey; Teva Pharmaceuticals USA of North Wales, Pennsylvania; and Teva Pharmaceutical Industries, Ltd. of Petach Tikva, Israel infringed its rights in United States Patent No. 7,772,209 (“the ’209 patent”) for “Antifolate Combination Therapies”. [read post]
15 Nov 2017, 4:00 am by Kimberly A. Kralowec
Actavis, Inc., ___ Cal.App.5th ___ (Nov. 6, 2017), the Court of Appeal (Fourth Appellate District, Division Three) considered whether the defendant pharmaceutical companies' CGL insurance policies required the insurers to defend a UCL "public prosecutor" action brought by Santa Clara and Orange Counties. [read post]
8 Nov 2017, 10:48 pm
THE VOTE - has the decision in Actavis v Eli Lilly improved the law? [read post]
8 Nov 2017, 5:29 am
  The key point of the Actavis case is article 69 of the EPC and the Protocol on interpretation. [read post]